420,000 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Compass Rose Asset Management LP

Compass Rose Asset Management LP acquired a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 420,000 shares of the biopharmaceutical company’s stock, valued at approximately $21,550,000. Bristol-Myers Squibb makes up approximately 9.0% of […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Turtle Creek ,Pomalyst Imnovid ,Bristol Myers Squibb ,William Blair ,Pacific Capital Wealth Advisors Inc ,Turtle Creek Wealth Advisors ,Barclays ,Bristol Myers Squibb Company ,Wetzel Investment Advisors Inc ,Visionpoint Advisory Group ,Wells Fargo Company ,Compass Rose Asset Management ,Free Report ,Myers Squibb ,Financial Advisors ,Capital Wealth Advisors ,Creek Wealth Advisors ,Investment Advisors ,Point Advisory Group ,Wells Fargo ,Get Free Report ,Myers Squibb Company ,Bristol Myers Squibb Daily ,